|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/454 | |
| A61P 25/18 |
| (11) | Patento numeris | 2825167 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13721817.8 |
| Europos patento paraiškos padavimo data | 2013-03-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/031413 |
| Data | 2013-03-14 |
| (87) | Numeris | WO 2013/138602 |
| Data | 2013-09-19 |
| (30) | Numeris | Data | Šalis |
| 201261610664 P | 2012-03-14 | US |
| (72) |
PHADKE, Deepak, US
WOLFGANG, Curt D., US
POLYMEROPOULOS,Mihael H., US
FEENEY, John Joseph, US
BIRZNIEKS, Gunther, US
|
| (73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037,
US
|
| (54) | AN ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS |
| AN ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS |